Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Phathom Pharmaceuticals (PHAT) Treasury Shares (2022 - 2025)

Historic Treasury Shares for Phathom Pharmaceuticals (PHAT) over the last 4 years, with Q3 2025 value amounting to $19.0.

  • Phathom Pharmaceuticals' Treasury Shares changed 0.0% to $19.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $19.0, marking a year-over-year change of 0.0%. This contributed to the annual value of $19.0 for FY2024, which is 0.0% changed from last year.
  • As of Q3 2025, Phathom Pharmaceuticals' Treasury Shares stood at $19.0, which was down 0.0% from $19.0 recorded in Q2 2025.
  • Phathom Pharmaceuticals' Treasury Shares' 5-year high stood at $699624.0 during Q2 2022, with a 5-year trough of $19.0 in Q1 2022.
  • Moreover, its 4-year median value for Treasury Shares was $19.0 (2022), whereas its average is $56282.8.
  • As far as peak fluctuations go, Phathom Pharmaceuticals' Treasury Shares surged by 16750000.0% in 2023, and later plummeted by 9994.03% in 2024.
  • Quarter analysis of 4 years shows Phathom Pharmaceuticals' Treasury Shares stood at $19.0 in 2022, then changed by 0.0% to $19.0 in 2023, then changed by 0.0% to $19.0 in 2024, then changed by 0.0% to $19.0 in 2025.
  • Its Treasury Shares stands at $19.0 for Q3 2025, versus $19.0 for Q2 2025 and $19.0 for Q1 2025.